VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Lai on Risk Factors Associated With Glioma

Rose K. Lai, MD
Published: Sunday, Apr 17, 2016



Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case-Control Study.

In the study, which investigated risk factors in 4000 newly diagnosed patients with glioma, researchers sought to determine whether aspirin or non-steroidal anti-inflammatory agents (NSAIDs) were associated with a risk of disease. Earlier, smaller studies also looking at the association have demonstrated conflicting results, Lai says. However, recent evidence suggests that aspirin is associated with a lower risk of glioma. 

Results of this study showed that aspirin was linked with a significant protective effect for patients with glioma; however, NSAIDs were only associated with reduced glioma risk in women.

<<< View more from the 2016 AACR Annual Meeting



Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case-Control Study.

In the study, which investigated risk factors in 4000 newly diagnosed patients with glioma, researchers sought to determine whether aspirin or non-steroidal anti-inflammatory agents (NSAIDs) were associated with a risk of disease. Earlier, smaller studies also looking at the association have demonstrated conflicting results, Lai says. However, recent evidence suggests that aspirin is associated with a lower risk of glioma. 

Results of this study showed that aspirin was linked with a significant protective effect for patients with glioma; however, NSAIDs were only associated with reduced glioma risk in women.

<<< View more from the 2016 AACR Annual Meeting


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x